SEYLANMED
SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis. SeylanMED is committed to the development of a topical Akt inhibitor as a first in class treatment for Seborrheic Keratosis (SK). Our lead drug candidate, SM-020, is the first molecularly-targeted approach for the treatment of SK. SeylanMED is funded by angel investors including board-certified dermatologists.
SEYLANMED
Industry:
Biotechnology Life Science Wellness
Founded:
2016-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.seylanmed.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.17 M USD
Technology used in webpage:
Domain Not Resolving PHP
Current Employees Featured
Founder
More informations about "SeylanMED"
SeylanMED - Crunchbase Company Profile & Funding
SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis. SeylanMED is committed to the development of a topical Akt inhibitor as a first in class …See details»
SeylanMED Company Profile 2024: Valuation, Investors ... - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for SeylanMED. Use the PitchBook Platform to explore the full profile.See details»
SeylanMED - Contacts, Employees, Board Members, Advisors
SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis.See details»
SeylanMED - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 24, 2019:See details»
SeylanMED - Products, Competitors, Financials, Employees, …
About SeylanMED. SeylanMED is a biotech company intended to develop treatments for seborrheic keratosis. The company’s lead drug candidate (SM-020) is a molecularly targeted …See details»
SeylanMED Financial Overview, Employee Count, and Competitors
SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis.SeylanMED is committed to the development of a topical Akt inhibitor as a first in …See details»
DermBiont Announces Acquisition of SeylanMED to Expand its ...
Nov 10, 2022 BOSTON, MA, October 21, 2020 – DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded ...See details»
DermBiont Announces Acquisition of SeylanMED - Healthcare …
Oct 22, 2020 DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the …See details»
DermBiont Announces Acquisition of SeylanMED to Expand its …
BOSTON, MA, October 21, 2020 – DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic …See details»
SeylanMED Stock Price, Funding, Valuation, Revenue & Financial …
Oct 21, 2020 Funding, Valuation & Revenue. 2 Fundings. SeylanMED has raised $1.17M over 2 rounds.. SeylanMED's latest funding round was a Acquired for on October 21, 2020.See details»
SeylanMED - Crunchbase
SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis.See details»
Video Laringoskop | Ceylan Med | Türkiye
Ceylan Med Sağlık sektörünün Medikal alanında Mikrobiyota, Kullanıma hazır Patoloji kabları, video laringoskop, Video bronkoskop, Video Nazofaringoskop, cihaz ve genel sarf satışı …See details»
Bronkoskop - Ceylan Med
Video BronkoskopSee details»
İletişim | Ceylan Med
[email protected] [email protected] Açık Rıza Metni'ni okudum, kabul ediyorum. Gönder. Gönderdiğiniz için teşekkür ederiz! Etiket : Video Laringoskop,Bronkoskop,Patoloji …See details»
DermBiont acquires SeylanMED - 2020-10-21 - Crunchbase
Oct 21, 2020 Acquired Organization: SeylanMED SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis. Acquiring Organization: DermBiont …See details»
Hava Yolu Yönetim Sistemi | Ceylan Med | Türkiye
Dokunmatik ekranlı Video Flexible Bronkoskop. Teknik Özellikler: 3,5 "renkli dokunmatik ekran ve yüksek çözünürlüklü 640 x 480. Fotoğraf ve video kayıt imkanıSee details»
SeylanMED - Tech Stack, Apps, Patents & Trademarks - Crunchbase
SeylanMED is a biotech company that develops a targeted therapy for Seborrheic Keratosis.See details»
Patoloji Kapları - Kullanıma Hazır | Ceylan Med
Serosep -Histopot Kullanıma hazır patoloji kaplarının üretimini kullanır. Bu kaplar Histoloji, Patoloji, Ameliyathane, Doğumhane, Girişimsel Radyoloji, Bronkoskopi, Plastik Cerrahi, Genel …See details»
Video Laringoskop - Ceylan Med
Teknik Özellikler: 3,5 "renkli dokunmatik ekran ve yüksek çözünürlüklü 640 x 480. Fotoğraf ve video kayıt imkanı. Harici bir monitöre bağlanabilir (HDMI bağlantısı)See details»
Microbiota - Ceylan Med
Mikrobiota Kavramı İlk kez Nobel ödüllü Prof.Dr. Joshua Lederberg tarafından “Hastalığın ve sağlığın belirleyicisi,Kommensal simbiyotik ve patojenik mikroorganizmalarla ortak alan …See details»